Physician

Christopher Louis Wixon, M.D.

According to 2025 Medicare claims, Christopher Wixon, M.D. (NPI: 1407882582) practices vascular surgery in the Hilton Head Island-Bluffton-Port Royal, SC market, with the plurality of this provider's patient population coming from Beaufort, SC. This provider's primary affiliated billing organization is SAVANNAH VASCULAR INSTITUTE, LLC (NPI: 1184873390; TIN: 26-1758203) and primary practice location at 29910-4779.

Wixon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 934 traditional Medicare patients, billed 5,841 HCPCS/CPT codes, and received $555,309 in Medicare payments. The top billing code was 93880 (Ultrasound of both sides of head and neck blood flow). Part D data shows 597 prescription claims across 170 beneficiaries totaling $115,123 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 24 claims. Open Payments data shows 35 records totaling $10,185. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $25,415 to $115,123. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $23,111 to $11,009.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	874	5,693	$635,434
2016	701	2,280	$506,693
2017	719	2,337	$447,915
2018	865	2,493	$538,525
2019	864	2,973	$514,617
2020	839	2,713	$587,382
2021	863	2,740	$573,474
2022	915	2,716	$556,005
2023	886	4,377	$626,139
2024	934	5,841	$555,309

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	176	739	$25,415
2016	185	694	$28,215
2017	195	830	$43,224
2018	188	753	$48,886
2019	154	562	$40,422
2020	162	498	$57,474
2021	157	520	$69,150
2022	170	496	$89,399
2023	203	615	$107,270
2024	170	597	$115,123

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	77	236	$54,416
2016	48	125	$29,417
2017	N/R	105	$12,480
2018	N/R	65	$7,530
2019	N/R	13	$224
2020	N/R	N/R	N/R
2021	N/R	24	$1,204
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93880	Ultrasound of both sides of head and neck blood flow	228	247	$131
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	144	144	$114
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	298	398	$89
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	189	189	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	440	562	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	95	4,155	$78,059
Xarelto	Rivaroxaban	34	1,619	$29,510
Clopidogrel	Clopidogrel Bisulfate	103	7,640	$998
Atorvastatin Calcium	Atorvastatin Calcium	37	2,250	$333
Gabapentin	Gabapentin	25	825	$250

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$10,185	AngioDynamics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Louis Wixon, M.D.?

Tedicare shows public-source Medicare data for Christopher Louis Wixon, M.D. (NPI 1407882582), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Louis Wixon, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher Louis Wixon, M.D.?

Christopher Louis Wixon, M.D. is linked to SAVANNAH VASCULAR INSTITUTE, LLC (billing NPI 1184873390) in the available physician profile data.

Does Christopher Louis Wixon, M.D. have Open Payments data?

Christopher Louis Wixon, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.